Emory University

University / College


Location: Atlanta, GA, United States (USA) (US) US

ISNI: 0000000109416502

ROR: https://ror.org/03czfpz43

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis (2021) Zlotoff DA, Hassan MZ, Zafar A, Alvi RM, Awadalla M, Mahmood SS, Zhang L, et al. Journal article Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group (2021) Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, et al. Journal article, Review article Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? (2021) Ho K, Fleseriu M, Kaiser U, Salvatori R, Brue T, Lopes MB, Kunz P, et al. Journal article Idecabtagene vicleucel in relapsed and refractory multiple myeloma (2021) Munshi NC, Anderson LD, Shah N, Madduri D, Berdeja J, Lonial S, Raje N, et al. Journal article Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation (2021) Lopez JP, Brivio E, Santambrogio A, De Donno C, Kos A, Peters M, Rost N, et al. Journal article The Journal of Cardiovascular Computed Tomography: 2020 Year in review (2021) Villines TC, Al'Aref SJ, Andreini D, Chen MY, Choi AD, De Cecco CN, Dey D, et al. Journal article Adaptive physiological water conservation explains hypertension and muscle catabolism in experimental chronic renal failure (2021) Kovarik J, Morisawa N, Wild J, Marton A, Takase-Minegishi K, Minegishi S, Daub S, et al. Journal article The Magic Biomarker Algorithm Predicts Outcomes for Children with Acute Graft Versus Host Disease (2020) Qayed M, Kapoor U, Gillespie S, Mccracken C, Abusin G, Aguayo-Hiraldo P, Ayuk F, et al. Conference contribution Immunotherapy for advanced or metastatic urothelial carcinoma (2020) Maisch P, Hwang EC, Narayan V, Bakker CJ, Kunath F, Dahm P Journal article Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article